Cardiovascular Drugs Practice Questions

Q: Fish oil is not used in the treatment of:

Type 2A Hyperlipoproteinemia. ***Type 2A Hyperlipoproteinemia*** - **Fish oil** (omega-3 fatty acids) primarily lowers **triglyceride** levels. - In **Type 2A hyperlipoproteinemia**, the main lipid abnormality is elevated **LDL cholesterol**, with normal triglycerides, making fish oil less effective as a primary treatment. *Type 2B Hyperlipoproteinemia* - This condition involves elevated **LDL cholesterol** and moderately elevated **triglycerides**. - **Fish oil** can be beneficial in managing the elevated triglyceride component. *Type 5 Hyperlipoproteinemia* - Characterized by very high **triglyceride** levels and elevated **chylomicrons** and **VLDL**. - **Fish oil** is a key therapeutic agent for significantly reducing triglycerides in this severe form of hyperlipidemia. *Type 3 Hyperlipoproteinemia* - Also known as **familial dysbetalipoproteinemia**, this condition involves elevated **chylomicron remnants** and **VLDL remnants**. - **Fish oil** can help lower the triglyceride-rich lipoproteins seen in this disorder.

Q: Which drug is primarily known for inhibiting cardiac remodeling in congestive heart failure (CHF)?

ACE inhibitors. ***ACE inhibitors*** - **Angiotensin-converting enzyme (ACE) inhibitors** prevent the conversion of angiotensin I to angiotensin II, reducing detrimental effects like **vasoconstriction**, **aldosterone secretion**, and **cardiac hypertrophy**. - By inhibiting the **renin-angiotensin-aldosterone system (RAAS)**, ACE inhibitors effectively reduce cardiac preload and afterload, leading to the prevention or reversal of **cardiac remodeling**. *Digitalis* - Digitalis primarily acts as a **positive inotrope**, increasing the force of myocardial contraction, and slowing the heart rate, particularly in **atrial fibrillation**. - While it improves symptoms, it does not directly prevent or reverse **cardiac remodeling** and can have a narrow therapeutic index. *Diuretics* - Diuretics primarily reduce **fluid overload** and congestion in CHF by increasing **sodium and water excretion**, thereby decreasing preload. - They alleviate symptoms like **edema** and **dyspnea** but do not directly target or inhibit the underlying processes of **cardiac remodeling**. *Vasodilators* - Vasodilators (such as nitrates and hydralazine) reduce **cardiac preload** and/or **afterload**, improving symptomatic relief. - While they can improve hemodynamics, their primary action is not focused on preventing the cellular and structural changes associated with **cardiac remodeling**.

Q: Which of the following is a Rho kinase inhibitor?

Fasudil. ***Fasudil*** - **Fasudil** is a well-known and clinically used **Rho kinase inhibitor**, primarily used in Japan for the treatment of **cerebral vasospasm** after subarachnoid hemorrhage. - It works by inhibiting the phosphorylation of **myosin light chain**, leading to **vasodilation**. *Ranolazine* - **Ranolazine** is an anti-anginal drug that works by selectively inhibiting the **late sodium current (I_Na)** in cardiac myocytes. - This reduces intracellular sodium and calcium overload, thereby improving myocardial relaxation and reducing oxygen demand, but it has no direct inhibitory effect on Rho kinase. *Amiloride* - **Amiloride** is a **potassium-sparing diuretic** that directly inhibits the **epithelial sodium channel (ENaC)** in the collecting duct. - It is used to treat **hypertension** and heart failure, preventing potassium loss, and is not associated with Rho kinase inhibition. *Nicorandil* - **Nicorandil** is an anti-anginal drug with a dual mechanism, acting as both a **potassium channel opener** and a **nitrate donor**. - Its vasodilatory effects are mediated through increasing cGMP (like nitrates) and hyperpolarizing vascular smooth muscle cells (like potassium channel openers), but it is not a Rho kinase inhibitor.

Q: All of the following are seen in digitalis toxicity except:

Paroxysmal atrial tachycardia with fast ventricular rate. ***Paroxysmal atrial tachycardia with fast ventricular rate*** - Digitalis toxicity typically causes **bradyarrhythmias** or **tachyarrhythmias** with AV block, leading to a slow or normal ventricular rate. - A **fast ventricular rate** in the presence of paroxysmal atrial tachycardia (PAT) suggests that the AV node is conducting impulses unimpeded, which is less likely in digitalis toxicity due to its negative dromotropic effects. *Ventricular bigeminy* - This is a **classic arrhythmia** seen in digitalis toxicity, characterized by alternating normal and premature ventricular beats. - Digitalis increases intracellular calcium and can lead to **delayed afterdepolarizations**, initiating ventricular ectopy. *Regularization of atrial fibrillation* - Digitalis can **slow AV nodal conduction** and increase ventricular refractoriness, which may lead to regularization of the ventricular response in atrial fibrillation. - While not a complete reversal of atrial fibrillation, the **ventricular rhythm becomes more regular** due to increased AV nodal block. *Bidirectional ventricular tachycardia* - This is a highly specific but **rare arrhythmia** associated with severe digitalis toxicity, characterized by alternating QRS complexes in opposite directions. - It results from enhanced automaticity and altered conduction properties in the **His-Purkinje system**.

Q: The drug of choice for prompt relief of an ongoing attack of angina precipitated by exercise or emotional stress is:

Sublingual nitroglycerin. ***Sublingual nitroglycerin*** - **Sublingual nitroglycerin** acts rapidly (within 1-3 minutes) by causing **vasodilation**, primarily of veins, which reduces **preload** and myocardial oxygen demand, providing prompt relief of anginal symptoms. - It works by releasing **nitric oxide**, leading to **smooth muscle relaxation** in blood vessels, which is critical for acute attack termination. *Propranolol* - **Propranolol** is a **beta-blocker** used for long-term prevention of angina by reducing heart rate and contractility, thereby decreasing oxygen demand. - It is **not suitable for acute relief** as its onset of action is not rapid enough to abort an ongoing anginal attack. *Verapamil* - **Verapamil** is a **calcium channel blocker** that reduces heart rate, contractility, and causes vasodilation, making it useful for angina prevention. - While it can improve oxygen supply, its onset of action is **too slow** for acute symptomatic relief of an ongoing anginal attack. *Sublingual nifedipine* - **Nifedipine** is a **dihydropyridine calcium channel blocker** predominantly used for hypertension and stable angina, primarily causing arterial vasodilation. - Sublingual nifedipine can cause a **rapid and substantial drop in blood pressure**, which can lead to reflex tachycardia and potentially worsen angina or cause adverse cardiovascular events; therefore, it is **not recommended for acute anginal relief**.

Q: ACE inhibitors, when used for a long time in hypertensive patients, cause

Reduction in filtration fraction. **Reduction in filtration fraction** - ACE inhibitors cause **vasodilation of the efferent arteriole** in the glomerulus. - This vasodilation leads to a **decrease in glomerular filtration pressure**, thereby reducing the filtration fraction. *Rightward shift in Renal pressure natriuresis curve* - A rightward shift in the renal pressure natriuresis curve indicates that a **higher blood pressure is required to excrete the same amount of sodium and water**. - ACE inhibitors typically cause a **leftward shift of this curve** by improving sodium and water excretion at lower pressures. *Significant increase in heart rate* - ACE inhibitors typically cause a **decrease or no significant change in heart rate**, as they interfere with the renin-angiotensin-aldosterone system (RAAS), which can affect sympathetic tone. - A significant increase in heart rate is **not a common or expected side effect** of long-term ACE inhibitor use. *No change in the compliance of large arteries* - Long-term use of ACE inhibitors can actually **improve arterial compliance** by remodeling the vessel walls and reducing stiffness. - This effect contributes to their **beneficial cardiovascular outcomes** beyond just blood pressure reduction.

Q: Atenolol is indicated in all except:

Partial heart block. ***Partial heart block*** - Beta-blockers like atenolol are **contraindicated** in patients with **partial heart block** (second- or third-degree AV block) as they can further depress AV nodal conduction, worsening the block and potentially leading to **bradycardia** or complete heart block [3]. - This adverse effect is due to their action on beta-1 adrenergic receptors in the heart, which reduces heart rate and conduction velocity [3]. *Hypertension* - Atenolol is a **beta-1 selective blocker** commonly used in the treatment of hypertension [1]. - It lowers blood pressure by reducing cardiac output and inhibiting **renin release** from the kidneys [1]. *Hypertrophic obstructive cardiomyopathy* - Beta-blockers, including atenolol, are often used in **hypertrophic obstructive cardiomyopathy (HOCM)** to reduce the **left ventricular outflow tract (LVOT)** obstruction. - They achieve this by increasing **diastolic filling time** and reducing myocardial contractility. *Classical angina* - Atenolol is effective in managing **classical angina** (stable angina) by reducing **myocardial oxygen demand** [2]. - It decreases heart rate, contractility, and blood pressure, thereby alleviating anginal symptoms [2].

Q: Which of the following medications is known to cause dysgeusia?

Captopril. ***Captopril*** - **Captopril**, an ACE inhibitor, is well-known for causing taste disturbances, specifically **dysgeusia** (altered taste sensation) or **ageusia** (loss of taste). - This side effect is thought to be related to its **sulfhydryl group** [1], which can chelate zinc, a metal crucial for normal taste perception. *Enalapril* - While also an ACE inhibitor, **enalapril** rarely causes taste disturbances compared to captopril. - It lacks the **sulfhydryl group** present in captopril, which is implicated in the mechanism of dysgeusia. *Ramipril* - **Ramipril** is another ACE inhibitor not commonly associated with dysgeusia. - Its chemical structure does not contain the **sulfhydryl group** that is linked to taste alterations. *Lisinopril* - **Lisinopril**, like enalapril and ramipril, is an ACE inhibitor that **seldom** causes dysgeusia. - The absence of the **sulfhydryl group** is a key differentiator from captopril regarding this specific side effect.

Q: Which drug is primarily associated with QT prolongation?

Quinidine. ***Quinidine*** - **Quinidine** is a Class IA antiarrhythmic drug that blocks **sodium channels** and also prolongs the **repolarization** phase of the action potential by blocking potassium channels, leading to **QT prolongation**. - Significant **QT prolongation** can predispose to **Torsades de pointes**, a polymorphic ventricular tachycardia. *Magnesium Sulfate* - **Magnesium sulfate** is used to treat **Torsades de pointes**, not cause it, as it stabilizes cardiac membranes and reduces arrhythmogenic activity. - While it can affect cardiac conduction, its primary effect is not **QT elongation** in a proarrhythmic way. *Lignocaine* - **Lignocaine** (Lidocaine) is a Class IB antiarrhythmic drug that primarily blocks **sodium channels** and **shortens** the action potential duration in some cardiac tissues. - It typically **does not cause QT prolongation** and is often used for ventricular arrhythmias without significant risk of Torsades de pointes. *Amiodarone* - **Amiodarone** is a Class III antiarrhythmic drug that causes **QT prolongation** by blocking potassium channels. - While it can prolong the QT interval, **Quinidine** is more classically and primarily associated with this effect, especially in causing **Torsades de pointes** as a side effect.

Question 1

Fish oil is not used in the treatment of:

Accepted Answer

Type 2A Hyperlipoproteinemia

Answer

Type 2B Hyperlipoproteinemia

Answer

Type 5 Hyperlipoproteinemia

Answer

Type 3 Hyperlipoproteinemia

Question 2

Which drug is primarily known for inhibiting cardiac remodeling in congestive heart failure (CHF)?

Accepted Answer

ACE inhibitors

Answer

Digitalis

Answer

Diuretics

Answer

Vasodilators

Question 3

Which of the following is a Rho kinase inhibitor?

Accepted Answer

Fasudil

Answer

Ranolazine

Answer

Amiloride

Answer

Nicorandil

Question 4

All of the following are seen in digitalis toxicity except:

Accepted Answer

Paroxysmal atrial tachycardia with fast ventricular rate

Answer

Ventricular bigeminy

Answer

Regularization of atrial fibrillation

Answer

Bidirectional ventricular tachycardia

Question 5

The drug of choice for prompt relief of an ongoing attack of angina precipitated by exercise or emotional stress is:

Accepted Answer

Sublingual nitroglycerin

Answer

Propranolol

Answer

Verapamil

Answer

Sublingual nifedipine

Question 6

ACE inhibitors, when used for a long time in hypertensive patients, cause

Accepted Answer

Reduction in filtration fraction

Answer

Rightward shift in Renal pressure natriuresis curve

Answer

Significant increase in heart rate

Answer

No change in the compliance of large arteries

Question 7

Atenolol is indicated in all except:

Accepted Answer

Partial heart block

Answer

Hypertension

Answer

Hypertrophic obstructive cardiomyopathy

Answer

Classical angina

Question 8

Which of the following medications is known to cause dysgeusia?

Accepted Answer

Captopril

Answer

Enalapril

Answer

Ramipril

Answer

Lisinopril

Question 9

The positive inotropic effect of digitalis is due to inhibition of Na+/K+ ATPase pump in cardiac muscle cell membrane leading to:

Accepted Answer

Decreased activity of Na+/Ca++ exchanger causing decreased influx of sodium and decreased efflux of Ca++ in the sarcolemma

Answer

Increased intracellular Na+ decreasing the activity of Ca++ pump in the sarcoplasmic reticulum

Answer

Increased intracellular Na+ causing increased efflux of Na+ and increased influx of Ca++ through Na+/Ca++ exchanger in the sarcolemma

Answer

Decreased efflux of Na+ leading to less negative resting membrane potential and opening of voltage gated Ca++ channels on the T tubules

Question 10

Which drug is primarily associated with QT prolongation?

Accepted Answer

Quinidine

Answer

Magnesium Sulfate

Answer

Lignocaine

Answer

Amiodarone

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?